GlobeNewswire by notified



Ad-hoc notice pursuant to Article 53 of the Listing Rules of the SIX Exchange Regulation


  • Sales increase in local currencies of 21.9%
  • First quarter sales of CHF 2,398.2 million (+20.0% in CHF)
  • Negative currency effect of –1.9%
  • Opening of new plants in Tanzania and Ivory Coast
  • Outlook for fiscal 2022 confirmed
    • Sales increase in local currencies by well over 10%, surpassing CHF 10 billion for the first time
    • Over-proportional increase in EBIT
    • Closing of MBCC acquisition remains targeted for the second half of 2022
    • Confirmation of 2023 strategic targets for sustainable, profitable growth

In the first quarter of 2022, Sika once again performed strongly in a challenging market environment. Despite supply shortages in raw materials and a highly inflationary environment, Sika significantly increased sales, posting a new record figure of CHF 2,398.2 million. This equates to an increase of 21.9% in local currencies compared to the previous year (CHF 1,998.6 million). All regions were able to tap into the dynamic momentum of the construction economy and contribute to the strong sales growth. Sales growth in Swiss francs amounted to 20.0%, which includes a negative currency effect of –1.9%. The acquisition effect was 4.3%. Organic growth in the first quarter amounted to 17.6%.

Thomas Hasler, Chief Executive Officer: “In the first quarter of the current fiscal year, we were confronted by ongoing strong raw material price increases. In addition to solid volume growth, we were able to implement consistent price adjustments. With our environmentally-friendly and innovative solutions we are positioning ourselves as a sustainability champion, and together with our customers, making a key contribution to climate neutrality in the construction and transportation industries. This first and foremost benefits the environment as well as current and future generations.”

The construction sector is benefiting from significant global economic support programs and is being shaped by the megatrend of climate change, which is ushering in a paradigm shift for the construction industry. Solutions for reducing CO2 emissions and conserving resources are becoming increasingly sought after in the world of construction. With its technologies, Sika is ideally positioned to offer its customers solutions that allow them to reduce their CO2 footprint, while at the same time enhancing longevity and minimizing the use of resources in construction. Thanks to the considerable demand for future-oriented, environmentally-friendly products, Sika was able to grow significantly in all regions in the first quarter of 2022.

The EMEA region (Europe, Middle East, Africa) reported a sales increase in local currencies of 18.1% (previous year: 13.2%). Above-average growth was recorded by the distribution and renovation business, as well as by the sale of Sika product solutions through e-commerce platforms. Nearly all countries in the region achieved double-digit growth rates. Particularly strong growth was recorded in the countries of Africa and the Middle East. Sika moved to a new site in the East African country of Tanzania in the period under review, and is now producing mortars locally in addition to concrete admixtures. Sika also extended its facility in Western Africa’s Ivory Coast. This site is now double its previous size and enjoys not only additional manufacturing facilities but also new warehousing capacities, office space, and laboratories.

The Americas region recorded growth in local currencies of 36.2% (previous year: 6.2%). The USA in particular exhibited a strong level of momentum in business. The key drivers here were
large-scale refurbishment and new-build projects in connection with distribution and data centers. Strong growth rates were reported by Mexico, Colombia, Brazil, and Chile. In the Americas region, the strategic focus of business activities on big cities and metropolitan areas continued to pay off, as did the concentration on major infrastructure projects and the targeted realization of cross-selling potential.

Sales in local currencies in the Asia/Pacific region increased by 18.6% (previous year: 25.8%). In China, it was mainly the distribution business that benefited from ongoing strong growth momentum, recording double-digit growth rates, whereas the project business was impacted by numerous lockdowns. Nevertheless, China as a whole achieved double-digit growth. India, Bangladesh, and Sri Lanka saw a dynamic development, while the countries in Southeast Asia and Japan managed to record high single-digit growth in challenging markets.

In the Global Business segment, Sika achieved growth in local currencies of 10.4% (previous year: 2.7%), and therefore grew more strongly than the market as a whole. The automotive industry once again saw significant supply chain bottlenecks. Sika anticipates continued strong growth stimuli from the megatrends evident in modern automotive production: electromobility and lightweight construction. In particular, the transition from traditional drive systems to electromobility has accelerated considerably over the last few years, and is being underpinned by a number of government support programs.

In November 2021, Sika signed a binding agreement to acquire the MBCC Group (the former BASF construction chemicals business). With sales of CHF 2.9 billion, the MBCC Group is a leading supplier of construction chemicals and solutions worldwide. The acquisition will complement and broaden Sika’s portfolio in four of five core technologies and seven of eight Sika Target Markets, while further strengthening the company’s geographic footprint. The transaction will give rise to a major player supporting greater sustainability.

The market for construction chemical products and solutions is set to grow to around CHF 80 billion over the next few years. As this market is heavily fragmented, it will continue to offer substantial growth opportunities, particularly in the area of sustainability. MBCC generates around 53% of its sales in the construction systems sector and the remaining 47% in the concrete admixtures segment. The acquisition is subject to approval by the authorities. Sika is confident it will receive all required clearances in a timely manner and will cooperate closely with the authorities to this end. The closing of the acquisition remains targeted for the second half of 2022.

Thanks to its innovative technologies, Sika is the partner of choice for many customers in the construction and industrial sectors. Government-supported investment programs running into the billions will provide further impetus for its business in the coming years. In addition, Sika is making targeted use of the megatrends that drive its key markets.

Based on these expectations, Sika is confirming its 2023 strategic targets. The company remains aligned for long-term success and profitable growth. With its focus on the six strategic pillars – market penetration, innovation, operational efficiency, acquisitions, strong corporate values, and sustainability – Sika is seeking to grow by 6%–8% a year in local currencies up to 2023. From 2021 onwards, the company is aiming to achieve an EBIT margin in the range of 15%–18%. Projects in the areas of operations, logistics, procurement, and product formulation should result in an annual improvement in operating costs equivalent to 0.5% of sales.

For fiscal 2022, Sika expects sales to rise by well over 10% in local currencies – surpassing CHF 10 billion for the first time – and is anticipating an over-proportional increase in EBIT.

The Annual General Meeting of Sika AG will take place at 4 p.m. CEST today, and will be broadcast live ( Prior to the lifting of key protective measures in connection with COVID-19, the Board of Directors decided – based on the Federal Council’s Ordinance on Measures to Combat the Coronavirus – that the persistently difficult situation makes it necessary to once again renounce physical participation at this year’s Annual General Meeting in order to protect the health of shareholders. Shareholders were given the opportunity to exercise their voting rights through the independent proxy. In addition, all shareholders have the opportunity to directly ask questions verbally during the meeting via an online platform. As part of the Annual General Meeting, Chief Executive Officer Thomas Hasler will comment on business development in the first quarter of 2022 as well as the outlook.


In CHF mn1.1.2021 -31.3.20211.1.2022 -31.3.2022Year-on-year change
(+/- in %)

In local currencies1Currency effectAcquisition effect2Organic
By region
EMEA 914.7 1,038.2 13.5 18.1 -4.6 0.5 17.6
Americas 482.1 662.9 37.5 36.2 1.3 7.0 29.2
Asia/Pacific 422.8 501.7 18.7 18.6 0.1 8.7 9.9
Global Business 179.0 195.4 9.2 10.4 -1.2 5.8 4.6
Net sales 1,998.62,398.220.021.9-1.94.317.6
Products for the construction industry 1,592.7 1,938.5 21.7 23.6 -1.9 2.8 20.8
Products for industrial manufacturing 405.9 459.7 13.3 15.1 -1.8 10.1 5.0
  1. Growth in local currencies including acquisitions.
  2. Share of sales of acquired companies not including post-combination growth. The sales growth of the acquired companies since initial consolidation is included in organic growth.
  3. Growth adjusted for acquisition and currency effects. The sales growth of the acquired companies since initial consolidation is included in organic growth.


Half-Year Report 2022 Friday, July 22, 2022
Results first nine months 2022 Friday, October 21, 2022
Net sales 2022 Wednesday, January 11, 2023
Media conference/analyst presentation
on 2022 full-year results Friday, February 17, 2023
Net sales first quarter 2023 Tuesday, April 18, 2023

Dominik Slappnig
Corporate Communications &
Investor Relations
+41 58 436 68 21

Sika is a specialty chemicals company with a leading position in the development and production of systems and products for bonding, sealing, damping, reinforcing, and protecting in the building sector and motor vehicle industry. Sika has subsidiaries in 101 countries around the world and manufactures in over 300 factories. Its over 27,000 employees generated annual sales of CHF 9.3 billion in 2021.

The media release can be downloaded from the following link:
Media Release

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Ted Elvhage, Board member in Fingerprint Cards AB (publ), has sold shares due to private financial commitments19.5.2022 14:14:57 CEST | Press release

Ted Elvhage, Board member in Fingerprint Cards AB, has sold 975,000 shares in Fingerprints. “The reason for my sale of shares is private financial commitments. I have an unchanged strong belief in the company's future and plan to invest in Fingerprints again as soon as it is possible for me to do so,” comments Ted Elvhage. Link to PDMR transactions register. For further information, please contact: Investor Relations: +46(0)10-172 00 10, Press: +46(0)10-172 00 20, About Fingerprints Fingerprint Cards AB (Fingerprints) – the world’s leading biometrics company, with its roots in Sweden. We believe in a secure and seamless universe, where you are the key to everything. Our solutions are found in hundreds of millions of devices and applications, and are used billions of times every day, providing safe and convenient identification and authentication with a human touch. For more information visit our website, read our blog, and follow us on

GOGL – Q1 2022 Presentation19.5.2022 13:59:16 CEST | Press release

Please find enclosed the presentation of Golden Ocean Group Limited’s first quarter 2022 results for today’s webcast / conference call at 15:00 CET. Attend by Webcast: Use to the follow link prior to the webcast: Attend by Conference Call: Applicable dial-in telephone numbers are as follows: International Dial-In: +44 (0) 2071 92 8338 United Kingdom Toll Free: 08002796619 Norway Toll Free: 800 56 865 US Toll-Free: +1 877 870 9135 The presentation material which will be used in the teleconference/webcast can be downloaded on and replay details will also be available at this website. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Golden Ocean Q1 2022 - Presentation

Vow ASA: Minutes of Annual General Meeting19.5.2022 12:40:04 CEST | Press release

The annual general meeting of Vow ASA was held today on 19 May 2022 at the company's premises at Lysaker Torg 12, 1366 Lysaker, Norway. All matters on the agenda were approved, cf. the notice of the Annual General Meeting that was published on 28 April 2022. The complete minutes are attached to this release. For further information, please contact: Erik Magelssen, CFO, Vow ASA Tel: +47 928 88 728 Email: About Vow Vow and its subsidiaries Scanship, C.H. Evensen and Etia are passionate about preventing pollution. The company’s world leading solutions convert biomass and waste into valuable resources and generate clean energy for a wide range of industries. Cruise ships on every ocean have Vow technology inside which processes waste and purifies wastewater. Fish farmers are adopting similar solutions, and public utilities and industries use our solutions for sludge processing, waste management and biogas production on land. With advanced technologies and solution

Bavarian Nordic modtager vaccineordre fra europæisk land efter bekræftede tilfælde af abekopper19.5.2022 11:46:42 CEST | pressemeddelelse

KØBENHAVN, Danmark, 19. maj 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har indgået en kontrakt med et unavngivet europæisk land vedrørende levering af koppevaccinen IMVANEX® i forbindelse med nye tilfælde af abekopper, der er identificeret i løbet af maj 2022. Det første europæiske tilfælde blev bekræftet den 7. maj 2022 hos en person, der vendte hjem fra en rejse til Nigeria, hvor abekopper er naturligt forekommende. Efterfølgende er der bekræftet mere end 20 tilfælde i England, Portugal og Spanien, og flere formodede tilfælde er ved at blive undersøgt. De fleste infektioner lader til at være sket lokalt i de tre lande. I USA er der bekræftet et enkelt tilfælde hos en rejsende fra Canada, hvor der endnu ikke foreligger bekræftede tilfælde, men adskillige formodede tilfælde er ved at blive undersøgt. Bavarian Nordics koppevaccine er godkendt i USA under navnet JYNNEOS® og i Canada under navnet IMVAMUNE®. I begge lande er godkendelsen udvidet til at omfatte abek

Bavarian Nordic Secures Vaccine Order from European Country After Confirmed Monkeypox Cases19.5.2022 11:46:42 CEST | Press release

COPENHAGEN, Denmark, May 19, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company has secured a contract with an undisclosed European country to supply its IMVANEX® smallpox vaccine in response to new cases of monkeypox evolving during May 2022. The first European case was confirmed on May 7, 2022, in an individual who returned from a travel to Nigeria, where monkeypox is endemic. Subsequently, more than 20 cases have been confirmed across England, Portugal and Spain with additional suspected cases currently being investigated. Evidence points to that most of the infections have been acquired locally in these countries. In the US, a single case has been confirmed in a traveler from Canada, where no cases are yet confirmed, but several remain under investigation. Bavarian Nordic’s smallpox vaccine is approved in the U.S. as JYNNEOS® and in Canada as IMVAMUNE®, both places with the approval extended to cover the monkeypox indication. The vaccine is approved in Europe a